The average selling price for EPIC PLUS in Japan dropped in 2022, according to GlobalData. The average selling price, the complete price range of high and low prices and a 3-year forecast for the EPIC PLUS device in Japan can be viewed in GlobalData’s micro pricing report. Buy the report here.
The EPIC PLUS is sold by Abbott Laboratories in the Tissue Sutured Mitral Valve Replacements market. Tissue sutured mitral valve replacements are used for replacement of the mitral heart valve using a biological prosthesis. One unit refers to one tissue sutured mitral valve replacement. Conventional suturing is used to keep these valves in desired place after surgery.
Factors contributing to the list price of a medical device include but are not limited to therapy area, complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. Moreover, final selling prices vary geographically and by facility type. These prices are further subject to discounts, as well as purchasing and distribution agreements.
For a complete picture of Abbott Laboratories’ Tissue Sutured Mitral Valve Replacements device pricing in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.